Drug Profile
Cord blood stem cell diabetes therapy - Gamida Cell
Alternative Names: GC 012; GC 013Latest Information Update: 12 Dec 2013
Price :
$50
*
At a glance
- Originator Gamida-Cell
- Class
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 12 Dec 2013 Discontinued - Preclinical for Diabetes mellitus in Israel (unspecified route)
- 15 Nov 2006 No development reported - Preclinical for Diabetes mellitus in Israel (unspecified route)
- 01 Jun 2004 Preclinical trials in Diabetes mellitus in Israel (unspecified route)